97 related articles for article (PubMed ID: 6191674)
1. [New direction in immunochemotherapy of cancer].
Nitta K
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1117-28. PubMed ID: 6191674
[TBL] [Abstract][Full Text] [Related]
2. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
Xu ZY; Hosokawa M; Morikawa K; Hatakeyama M; Kobayashi H
Cancer Res; 1988 Dec; 48(23):6658-63. PubMed ID: 2460226
[TBL] [Abstract][Full Text] [Related]
3. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
4. [Modification of suppressor activity and effector activity of tumor-bearing hosts by bleomycin].
Hosokawa M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):677-83. PubMed ID: 2421642
[TBL] [Abstract][Full Text] [Related]
5. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
6. [Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin].
Hosokawa M; Morikawa K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2700-8. PubMed ID: 6210061
[TBL] [Abstract][Full Text] [Related]
7. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
Ma J; Wang YL; Hu HM; Fox BA; Si LS
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
[TBL] [Abstract][Full Text] [Related]
8. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H
Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of immune response by an antitumor agent, cyclophosphamide].
Nitta K; Tanaka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):706-13. PubMed ID: 2938546
[TBL] [Abstract][Full Text] [Related]
10. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
11. [Possible clinical application of immunochemotherapy experimented in animals].
Hosokawa M
Gan To Kagaku Ryoho; 2000 Jun; 27(6):811-6. PubMed ID: 10897206
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
Mizushima Y; Sendo F; Miyake T; Kobayashi H
J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
[TBL] [Abstract][Full Text] [Related]
13. Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes.
Akiyama J; Kawamura T; Gotohda E; Yamada Y; Hosokawa M; Kodama T; Kobayashi H
Cancer Res; 1977 Sep; 37(9):3042-5. PubMed ID: 884662
[TBL] [Abstract][Full Text] [Related]
14. [Immunological analysis of chemotherapeutic effects for the effective immunochemotherapy against cancer].
Yamada Y
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):721-7. PubMed ID: 6397415
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
16. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
17. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y
Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
[TBL] [Abstract][Full Text] [Related]
18. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
Good MF; Nossal GJ
J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
[TBL] [Abstract][Full Text] [Related]
19. Host immune responses to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma.
Hosokawa M; Xu ZY; Morikawa K; Hamada J; Kobayashi H
Mol Biother; 1988; 1(2):74-80. PubMed ID: 2479397
[TBL] [Abstract][Full Text] [Related]
20. [Enhancement of antitumor immune responses by bleomycin].
Morikawa K
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]